Lex Witness to host 9th Annual Pharma Legal & Compliance Summit 2023 in Mumbai
The summit is scheduled for December 8, 2023 at the Courtyard by Marriott, Mumbai, Andheri East
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Regulations/Policies
Health Ministry releases draft National Pharmacy Commission Bill, 2023
It seeks to repeal the Pharmacy Act of 1948 and replace the Pharmacy Council of India with a national commission
NPPA slashes prices on 33 FDCs drugs
This move affects pharma companies like JB Chemicals, Eris Lifesciences, Zydus Healthcare, Cipla, Sun Pharma, Sanofi India, and…
Dr Mansukh Mandaviya launches national R&D and Innovation Policy and PRIP scheme
The scheme will focus on transforming India into a high-volume, high-value player in the global market of pharmaceuticals, meeting…
NCLAT validates insolvency resolution process in Hindustan National Glass case
Recognises AGI Greenpac's acquisition of HNG
DCGI issues advisory about Digene Gel following Abbott’s voluntary recall
The advisory instructs healthcare professionals to promptly report any suspicious cases of adverse events linked to this product
US FDA places partial clinical hold on Gilead’s studies on Magrolimab for AML treatment
The FDA action follows the previously announced discontinuation of the Phase 3 ENHANCE study of magrolimab in higher-risk…
Industry backlash may reshape EU compulsory pharma licensing reform: GlobalData
Both Johnson & Johnson and Pfizer criticised the changes by referencing the positive role of patents in incentivising their…
Pharma to face more pricing pain as new legislation expands scope of Inflation Reduction Act:…
Any successful legislation that builds off from the Inflation Reduction Act could signal further policy changes for US drug…
143 pharma companies get show cause notices from CDSCO post inspections
Mansukh Mandaviya, Union Health Minister divulged this information in a written reply to a question in Rajya Sabha